CBIZ (CBZ) is drawing attention after recent share price pressure, with the stock down over the past month and year. This has prompted investors to reassess its valuation and the factors influencing its underlying business performance.

For CBIZ, the share price has come under pressure recently, with a 1 day share price return showing a 2.63% decline and a year to date share price return down 40.16%. At the same time, the 90 day share price return of 16.34% suggests shorter term momentum has improved even as the 1 year total shareholder return fell 57.69%.

If that mix of pressure and recovery has you reassessing your watchlist, this may be a good moment to broaden your search using our screener for 20 top founder-led companies

With CBIZ trading at a discount to its analyst price target and an indicated intrinsic discount, the question is whether recent weakness has left the stock undervalued or if the market is already accounting for its future growth.

Most Popular Narrative: 25.9% Undervalued

CBIZ's most followed narrative places fair value at $41, well above the last close at $30.40, and frames that gap around measured growth and profitability assumptions.

The Marcum acquisition has significantly expanded CBIZ's client base, increased scale, and strengthened capabilities in core tax, accounting, and advisory services, enabling the firm to leverage cross-selling, deepen client relationships, and improve its competitive position in target middle-market segments. This is expected to support higher future revenue and structural margin expansion as integration synergies are realized.

Want to see how CBIZ's fair value depends on steady revenue gains, higher margins, and a tighter share count over time? The full narrative outlines the specific revenue trajectory, the profit mix behind it, and the valuation multiple that connects these elements.

Result: Fair Value of $41 (UNDERVALUED)

However, CBIZ investors still need to weigh pricing pressure, which could limit revenue growth, and the higher leverage from the Marcum deal that adds financial risk.

Next Steps

If the mixed sentiment around CBIZ has you on the fence, take a closer look at the underlying data and consider both the concerns and the potential upsides with 5 key rewards and 1 important warning sign

Looking for more investment ideas beyond CBIZ?

If CBIZ is on your radar, do not stop there. Broaden your search now and avoid missing other opportunities that could better match your goals.

• Target steadier opportunities by reviewing companies that screen well on resilience and risk through the 67 resilient stocks with low risk scores.
• Spot potential value candidates early by checking companies that combine quality fundamentals with attractive pricing via the 43 high quality undervalued stocks.
• Strengthen your watchlist with businesses that pair balance sheet stability and solid fundamentals using the solid balance sheet and fundamentals stocks screener (48 results).

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.